Patient Safety and Risk Software Market by Function (Incident Reporting, Compliance (Monitoring, Analytics, GRC), Clinical Safety (Infection Control), Claims Management), End User (Hospital, ASC, LTC, Payers), Deployment, and Region - Global Forecasts to 2030

1 INTRODUCTION 32 1.1 STUDY OBJECTIVES 32 1.2 MARKET DEFINITION 32 1.3 STUDY SCOPE 33 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 33 1.3.2 INCLUSIONS AND EXCLUSIONS 34 1.3.3 YEARS CONSIDERED 35 1.4 CURRENCY CONSIDERED 35 1.5 STAKEHOLDERS 35 2 RESEARCH METHODOLOGY 37 2.1 RESEARCH DATA 37 2.1.1 SECONDARY DATA 38 2.1.1.1 Key data from secondary sources 39 2.1.2 PRIMARY DATA 39 2.1.2.1 Key data from primary sources 41 2.1.2.2 Insights from primary experts 41 2.2 MARKET SIZE ESTIMATION 42 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 48 2.4 RESEARCH ASSUMPTIONS 50 2.4.1 MARKET SIZING ASSUMPTIONS 50 2.4.2 OVERALL STUDY ASSUMPTIONS 50 2.5 RESEARCH LIMITATIONS 51 2.5.1 METHODOLOGY-RELATED LIMITATIONS 51 2.5.2 SCOPE-RELATED LIMITATIONS 51 2.6 RISK ANALYSIS 51 3 EXECUTIVE SUMMARY 52 4 PREMIUM INSIGHTS 56 4.1 PATIENT SAFETY AND RISK SOFTWARE MARKET OVERVIEW 56 4.2 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER AND REGION 57 4.3 PATIENT SAFETY AND RISK SOFTWARE MARKET: GEOGRAPHIC SNAPSHOT 58 4.4 PATIENT SAFETY AND RISK SOFTWARE MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS 59   5 MARKET OVERVIEW 60 5.1 INTRODUCTION 60 5.2 MARKET DYNAMICS 60 5.2.1 DRIVERS 62 5.2.1.1 Rising patient safety incidents 62 5.2.1.2 Increasing prioritization of patient safety 63 5.2.1.3 Escalating healthcare costs and shift toward value-based care models 63 5.2.1.4 Increasing adoption of digital health technologies 64 5.2.2 RESTRAINTS 64 5.2.2.1 High implementation and maintenance costs 64 5.2.2.2 Resistance to adoption and perceived complexity of patient safety and risk software 65 5.2.2.3 Data privacy and interoperability challenges 65 5.2.3 OPPORTUNITIES 67 5.2.3.1 Growing adoption of AI, predictive analytics, and automation 67 5.2.3.2 Increasing adoption of patient safety and risk solutions into MedTech and pharma safety domains 67 5.2.3.3 Integration of patient safety and risk software with population health and real-world evidence platforms 68 5.2.4 CHALLENGES 68 5.2.4.1 Lack of global standardization in safety reporting 68 5.2.4.2 Complex integration with legacy systems 68 5.2.4.3 Limited awareness and underreporting of safety events 69 5.3 INDUSTRY TRENDS 69 5.3.1 MOBILE HEALTH PLATFORMS 69 5.3.2 CLOUD-BASED ALARM MANAGEMENT SOLUTION 69 5.3.3 IOT-ENABLED SOLUTIONS 69 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS 70 5.5 PRICING ANALYSIS 70 5.5.1 INDICATIVE PRICING ANALYSIS, BY KEY PLAYER 71 5.5.2 INDICATIVE PRICING ANALYSIS, BY REGION 71 5.6 VALUE CHAIN ANALYSIS 72 5.7 ECOSYSTEM ANALYSIS 73 5.8 INVESTMENT AND FUNDING SCENARIO 76 5.9 TECHNOLOGY ANALYSIS 76 5.9.1 KEY TECHNOLOGIES 76 5.9.1.1 AI-powered risk scoring 76 5.9.1.2 Automated root cause analysis 77 5.9.1.3 Real-time safety dashboards 77 5.9.1.4 Mobile incident reporting apps 77   5.9.2 ADJACENT TECHNOLOGIES 77 5.9.2.1 Cloud SaaS platforms 78 5.9.2.2 Blockchain 78 5.9.3 COMPLEMENTARY TECHNOLOGIES 78 5.9.3.1 EHR/EMR integration 78 5.9.3.2 Claims and billing systems 78 5.9.3.3 Credentialing systems 79 5.10 PATENT ANALYSIS 79 5.10.1 PATENT PUBLICATION TREND 79 5.10.2 LIST OF PATENTS 81 5.11 KEY CONFERENCES AND EVENTS, 2025–2027 82 5.12 CASE STUDY ANALYSIS 83 5.12.1 ADOPTION OF VIRTUAL OBSERVATION SOLUTION TO REDUCE FALL RATES IN PATIENTS 83 5.12.2 UTILIZATION OF ENTERPRISE RISK MANAGEMENT SYSTEM FOR ENHANCED PATIENT SAFETY 83 5.12.3 USE OF COMPREHENSIVE HEALTHCARE RISK MANAGEMENT SOFTWARE FOR IMPROVED REGULATORY COMPLIANCE 84 5.13 REGULATORY LANDSCAPE 84 5.13.1 REGULATORY ANALYSIS 84 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 5.14 PORTER’S FIVE FORCES ANALYSIS 92 5.14.1 BARGAINING POWER OF SUPPLIERS 93 5.14.2 BARGAINING POWER OF BUYERS 93 5.14.3 THREAT OF NEW ENTRANTS 93 5.14.4 THREAT OF SUBSTITUTES 93 5.14.5 INTENSITY OF COMPETITIVE RIVALRY 93 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 94 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 94 5.15.2 BUYING CRITERIA 95 5.16 END-USER ANALYSIS 95 5.16.1 UNMET NEEDS 95 5.16.2 END-USER EXPECTATIONS 96 5.17 BUSINESS MODEL 97 5.17.1 SUBSCRIPTION LICENSING 97 5.17.2 MODULAR PLATFORM APPROACH 97 5.17.3 IMPLEMENTATION AND INTEGRATION FEES 97 5.17.4 VALUE-ADDED SERVICES 97 5.17.5 MARKETPLACE INTEGRATION AND REGIONAL PRICING 97   5.18 IMPACT OF AI/GEN AI ON PATIENT SAFETY AND RISK SOFTWARE MARKET 98 5.18.1 INTRODUCTION 98 5.18.2 TOP USE CASES AND MARKET POTENTIAL 98 5.18.3 KEY USE CASES 99 5.18.4 CASE STUDY ON AI/GENERATIVE AI IMPLEMENTATION 100 5.18.4.1 Use of AI-powered data extraction platform with risk management software 100 5.18.5 INTERCONNECTED AND ADJACENT ECOSYSTEMS 101 5.18.5.1 Pharmacovigilance and drug safety monitoring 101 5.18.5.2 Healthcare information exchange 101 5.18.5.3 Quality improvement software 102 5.18.5.4 Healthcare GRC 102 5.18.6 USER READINESS AND IMPACT ASSESSMENT 102 5.18.6.1 Healthcare providers 102 5.18.6.2 Pharmaceutical & biotechnology companies 103 5.19 IMPACT OF 2025 US TARIFF 104 5.19.1 INTRODUCTION 104 5.19.2 KEY TARIFF RATES 105 5.19.3 PRICE IMPACT ANALYSIS 105 5.19.4 IMPACT ON COUNTRY/REGION 106 5.19.4.1 US 106 5.19.4.2 Europe 107 5.19.4.3 Asia Pacific 107 5.19.5 IMPACT ON END-USE INDUSTRIES 107 6 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION 109 6.1 INTRODUCTION 110 6.2 RISK & SAFETY MANAGEMENT 110 6.2.1 INCIDENT REPORTING SYSTEMS 111 6.2.1.1 Need for real-time reporting and automated workflows to support growth 111 6.2.2 EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE 112 6.2.2.1 Ability to analyze incident patterns and implement risk mitigation to promote growth 112 6.2.3 PATIENT LEARNING SYSTEMS 113 6.2.3.1 Increasing focus on improving patient safety to foster growth 113 6.3 COMPLIANCE & GOVERNANCE 114 6.3.1 RISK/COMPLIANCE MONITORING AND ANALYTICS SOFTWARE 115 6.3.1.1 Evolving need for continuous surveillance of organizational activities to aid growth 115 6.3.2 GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS 116 6.3.2.1 Growing shift from reactive compliance management to proactive risk prevention to boost market 116   6.4 CLINICAL SAFETY CONTROLS 117 6.4.1 MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE 118 6.4.1.1 Need to prevent medication errors to contribute to growth 118 6.4.2 INFECTION CONTROL SYSTEMS 119 6.4.2.1 Rise in proactive surveillance, rapid intervention, and continuous monitoring to expedite growth 119 6.5 FINANCIAL & LEGAL RISK HANDLING 120 6.5.1 CLAIMS MANAGEMENT SOLUTIONS 121 6.5.1.1 Need to leverage data-driven claims management to minimize costs to favor growth 121 6.5.2 REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS 122 6.5.2.1 Growing focus on minimizing financial and legal risks to propel market 122 7 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE 123 7.1 INTRODUCTION 124 7.2 ON-PREMISE DEPLOYMENT 124 7.2.1 HIGHER CONTROL, SECURITY, AND CUSTOMIZATION TO BOLSTER GROWTH 124 7.3 CLOUD-BASED DEPLOYMENT 125 7.3.1 NEED TO REDUCE IT OVERHEAD AND ENABLE FASTER INNOVATION TO SPUR GROWTH 125 7.4 HYBRID DEPLOYMENT 126 7.4.1 ABILITY TO SUPPORT REAL-TIME INCIDENT REPORTING, ROOT CAUSE ANALYSIS, AND COMPLIANCE MONITORING TO DRIVE MARKET 126 8 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER 128 8.1 INTRODUCTION 129 8.2 HEALTHCARE PROVIDERS 129 8.2.1 HOSPITALS 130 8.2.1.1 Rising demand for high-quality care and patient safety to accelerate growth 130 8.2.2 CLINICS 131 8.2.2.1 Increasing demand for quality care in outpatient and ambulatory settings to facilitate growth 131 8.2.3 AMBULATORY CARE CENTERS 132 8.2.3.1 Growing shift toward outpatient and value-based care models to drive market 132 8.2.4 LONG-TERM CARE CENTERS 133 8.2.4.1 Increasing focus on elderly care and patients with chronic conditions to aid growth 133 8.2.5 PHARMACIES 134 8.2.5.1 Enhanced medical safety and regulatory compliance to augment growth 134 8.2.6 OTHER HEALTHCARE PROVIDERS 135   8.3 PHARMACEUTICAL & BIOTECH COMPANIES 136 8.3.1 NEED TO MAINTAIN PRODUCT QUALITY, REGULATORY COMPLIANCE, AND PHARMACOVIGILANCE TO ENCOURAGE GROWTH 136 8.4 HEALTHCARE PAYERS 137 8.4.1 INCREASING ADOPTION OF PATIENT SAFETY AND RISK SOFTWARE FOR ENHANCED QUALITY ACROSS HEALTHCARE ECOSYSTEM TO AID GROWTH 137 8.5 MEDTECH COMPANIES 138 8.5.1 GROWING RISK OF DATA INTEGRITY AND CYBERSECURITY TO FUEL MARKET 138 8.6 OTHER END USERS 139 9 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION 140 9.1 INTRODUCTION 141 9.2 NORTH AMERICA 141 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 142 9.2.2 US 147 9.2.2.1 Increasing initiatives for improving patient and healthcare workforce safety to aid growth 147 9.2.3 CANADA 151 9.2.3.1 Rise in patient safety improvement programs to contribute to growth 151 9.3 EUROPE 155 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 155 9.3.2 GERMANY 160 9.3.2.1 Targeted government policies and push toward modernizing healthcare delivery to propel market 160 9.3.3 UK 164 9.3.3.1 Growing initiatives on improving patient outcomes and reducing medical errors to drive market 164 9.3.4 FRANCE 168 9.3.4.1 Increasing use of integrated digital platforms in hospitals to expedite growth 168 9.3.5 ITALY 172 9.3.5.1 Favorable national legislation and regional healthcare policies to promote growth 172 9.3.6 SPAIN 176 9.3.6.1 Rising commitment toward enhanced healthcare quality and culture of safety to aid growth 176 9.3.7 REST OF EUROPE 180 9.4 ASIA PACIFIC 184 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 184 9.4.2 CHINA 190 9.4.2.1 Increasing deployment of critical incident reporting systems and EHR-linked safety modules to fuel market 190 9.4.3 JAPAN 194 9.4.3.1 Growing focus on supporting error reporting, root cause analysis, and clinical protocols to boost market 194 9.4.4 INDIA 198 9.4.4.1 Strong public-private sector initiatives to support growth 198 9.4.5 AUSTRALIA 202 9.4.5.1 Increasing emphasis on quality improvement across public and private hospitals to spur growth 202 9.4.6 SOUTH KOREA 205 9.4.6.1 Innovation-driven healthcare ecosystem to facilitate growth 205 9.4.7 REST OF ASIA PACIFIC 210 9.5 LATIN AMERICA 214 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 214 9.5.2 BRAZIL 219 9.5.2.1 Increasing focus on reducing adverse events and hospital-acquired infections to encourage growth 219 9.5.3 MEXICO 223 9.5.3.1 Expanding healthcare digitization and national policies promoting patient safety to drive market 223 9.5.4 REST OF LATIN AMERICA 227 9.6 MIDDLE EAST & AFRICA 231 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 231 9.6.2 GCC COUNTRIES 235 9.6.2.1 Saudi Arabia 240 9.6.2.1.1 Increasing modernization efforts in healthcare to accelerate growth 240 9.6.2.2 UAE 243 9.6.2.2.1 Evolving digital health landscape to favor growth 243 9.6.2.3 Rest of GCC countries 248 9.6.3 SOUTH AFRICA 252 9.6.3.1 Increasing awareness about patient safety in public and private healthcare sectors to boost market 252 9.6.4 REST OF MIDDLE EAST & AFRICA 256 10 COMPETITIVE LANDSCAPE 260 10.1 INTRODUCTION 260 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 260 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET 260 10.3 REVENUE SHARE ANALYSIS, 2020–2024 262 10.4 MARKET SHARE ANALYSIS, 2024 263 10.5 BRAND/SOFTWARE COMPARISON 266 10.6 COMPANY VALUATION AND FINANCIAL METRICS 267 10.6.1 COMPANY VALUATION 267 10.6.2 FINANCIAL METRICS 267   10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 268 10.7.1 STARS 268 10.7.2 EMERGING LEADERS 268 10.7.3 PERVASIVE PLAYERS 268 10.7.4 PARTICIPANTS 268 10.7.5 COMPANY FOOTPRINT, 2024 270 10.7.5.1 Company footprint 270 10.7.5.2 Region footprint 271 10.7.5.3 Deployment mode footprint 272 10.7.5.4 Function footprint 273 10.7.5.5 End-user footprint 274 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 275 10.8.1 PROGRESSIVE COMPANIES 275 10.8.2 RESPONSIVE COMPANIES 275 10.8.3 DYNAMIC COMPANIES 275 10.8.4 STARTING BLOCKS 275 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 277 10.8.5.1 Detailed list of key startups/SMEs 277 10.8.5.2 Competitive benchmarking of key startups/SMEs 277 10.9 COMPETITIVE SCENARIO 278 10.9.1 SOLUTION LAUNCHES AND ENHANCEMENTS 278 10.9.2 DEALS 279 10.9.3 EXPANSIONS 280 11 COMPANY PROFILES 281 11.1 KEY PLAYERS 281 11.1.1 RISKONNECT, INC. 281 11.1.1.1 Business overview 281 11.1.1.2 Solutions offered 282 11.1.1.3 Recent developments 282 11.1.1.3.1 Solution launches and enhancements 282 11.1.1.3.2 Deals 283 11.1.1.4 MnM view 283 11.1.1.4.1 Right to win 283 11.1.1.4.2 Strategic choices 283 11.1.1.4.3 Weaknesses and competitive threats 283 11.1.2 ORIGAMI RISK LLC 284 11.1.2.1 Business overview 284 11.1.2.2 Solutions offered 284 11.1.2.3 Recent developments 285 11.1.2.3.1 Solution launches and enhancements 285 11.1.2.4 MnM view 285 11.1.2.4.1 Right to win 285 11.1.2.4.2 Strategic choices 285 11.1.2.4.3 Weaknesses and competitive threats 286 11.1.3 RLDATIX 287 11.1.3.1 Business overview 287 11.1.3.2 Solutions offered 287 11.1.3.3 Recent developments 288 11.1.3.3.1 Solution launches and enhancements 288 11.1.3.3.2 Deals 289 11.1.3.3.3 Expansions 291 11.1.3.4 MnM view 291 11.1.3.4.1 Right to win 291 11.1.3.4.2 Strategic choices 291 11.1.3.4.3 Weaknesses and competitive threats 291 11.1.4 HEALTH CATALYST 292 11.1.4.1 Business overview 292 11.1.4.2 Solutions offered 293 11.1.4.3 Recent developments 294 11.1.4.3.1 Solution launches and enhancements 294 11.1.4.3.2 Deals 294 11.1.5 SYMPLR 297 11.1.5.1 Business overview 297 11.1.5.2 Solutions offered 297 11.1.5.3 Recent developments 298 11.1.5.3.1 Solution launches and enhancements 298 11.1.5.3.2 Deals 298 11.1.5.4 MnM view 299 11.1.5.4.1 Right to win 299 11.1.5.4.2 Strategic choices 299 11.1.5.4.3 Weaknesses and competitive threats 299 11.1.6 CLARITY GROUP, INC. 300 11.1.6.1 Business overview 300 11.1.6.2 Solutions offered 300 11.1.7 PERFORMANCE HEALTH PARTNERS 301 11.1.7.1 Business overview 301 11.1.7.2 Solutions offered 301 11.1.7.3 Recent developments 302 11.1.7.3.1 Deals 302 11.1.8 MORCARE 303 11.1.8.1 Business overview 303 11.1.8.2 Solutions offered 303   11.1.9 RISKQUAL TECHNOLOGIES, INC. 304 11.1.9.1 Business overview 304 11.1.9.2 Solutions offered 304 11.1.10 PRISTA CORPORATION 305 11.1.10.1 Business overview 305 11.1.10.2 Solutions offered 305 11.1.11 SAFEQUAL 306 11.1.11.1 Business overview 306 11.1.11.2 Solutions offered 306 11.1.12 IQVIA 307 11.1.12.1 Business overview 307 11.1.12.2 Solutions offered 308 11.1.12.3 Recent developments 309 11.1.12.3.1 Solution launches and enhancements 309 11.1.12.3.2 Deals 309 11.1.13 INOVALON 310 11.1.13.1 Business overview 310 11.1.13.2 Solutions offered 310 11.1.13.3 Recent developments 311 11.1.13.3.1 Solution launches and enhancements 311 11.1.14 NAVEX GLOBAL, INC. 312 11.1.14.1 Business overview 312 11.1.14.2 Solutions offered 312 11.1.14.3 Recent developments 313 11.1.14.3.1 Solution launches and enhancements 313 11.1.14.3.2 Deals 314 11.1.14.3.3 Expansions 314 11.1.15 CENSINET 315 11.1.15.1 Business overview 315 11.1.15.2 Solutions offered 315 11.1.15.3 Recent developments 316 11.1.15.3.1 Solution launches and enhancements 316 11.1.16 AMERICAN DATA NETWORK 317 11.1.16.1 Business overview 317 11.1.16.2 Solutions offered 317 11.1.17 ARVENTA 318 11.1.17.1 Business overview 318 11.1.17.2 Solutions offered 318 11.1.18 COMPLIANCEQUEST 319 11.1.18.1 Business overview 319 11.1.18.2 Solutions offered 319 11.1.18.3 Recent developments 320 11.1.18.3.1 Solution launches and enhancements 320 11.1.18.3.2 Deals 320 11.1.19 RADAR HEALTHCARE INC 321 11.1.19.1 Business overview 321 11.1.19.2 Solutions offered 321 11.1.20 PASCAL METRICS INC. 322 11.1.20.1 Business overview 322 11.1.20.2 Solutions offered 322 11.2 OTHER PLAYERS 323 11.2.1 OMNIGO 323 11.2.2 LOGICMANAGER, INC. 324 11.2.3 DEXUR 325 11.2.4 HEALTHCARE GRC PTE LTD. 326 11.2.5 NOSOTECH INC. 327 12 APPENDIX 328 12.1 DISCUSSION GUIDE 328 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 333 12.3 CUSTOMIZATION OPTIONS 335 12.4 RELATED REPORTS 335 12.5 AUTHOR DETAILS 336

TABLE 1 FACTOR ANALYSIS 46 TABLE 2 PATIENT SAFETY AND RISK SOFTWARE MARKET: RISK ANALYSIS 51 TABLE 3 PATIENT SAFETY AND RISK SOFTWARE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 61 TABLE 4 NORTH AMERICA: HEALTHCARE DATA BREACHES, 2021–2025 65 TABLE 5 INDICATIVE PRICING ANALYSIS OF PATIENT SAFETY AND RISK SOFTWARE, BY KEY PLAYER, 2024 (USD) 71 TABLE 6 PATIENT SAFETY AND RISK SOFTWARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM 75 TABLE 7 PATIENT SAFETY AND RISK SOFTWARE MARKET: JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES, JANUARY 2022–SEPTEMBER 2025 80 TABLE 8 PATIENT SAFETY AND RISK SOFTWARE MARKET: LIST OF PATENTS, JANUARY 2022–SEPTEMBER 2025 81 TABLE 9 PATIENT SAFETY AND RISK SOFTWARE MARKET: KEY CONFERENCES AND EVENTS, 2025–2027 82 TABLE 10 REGULATORY SCENARIO IN NORTH AMERICA 84 TABLE 11 REGULATORY SCENARIO IN EUROPE 86 TABLE 12 REGULATORY SCENARIO IN ASIA PACIFIC 86 TABLE 13 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA 88 TABLE 14 REGULATORY SCENARIO IN LATIN AMERICA 88 TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89 TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 TABLE 20 PATIENT SAFETY AND RISK SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS 93 TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 94 TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS 95 TABLE 23 PATIENT SAFETY AND RISK SOFTWARE MARKET: UNMET NEEDS 96 TABLE 24 PATIENT SAFETY AND RISK SOFTWARE MARKET: END-USER EXPECTATIONS 96 TABLE 25 US ADJUSTED RECIPROCAL TARIFF RATES 105 TABLE 26 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 110 TABLE 27 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 111 TABLE 28 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 29 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR INCIDENT REPORTING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 30 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE, BY REGION, 2023–2030 (USD MILLION) 113 TABLE 31 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PATIENT LEARNING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 32 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 114 TABLE 33 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY REGION, 2023–2030 (USD MILLION) 115 TABLE 34 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK/COMPLIANCE MONITORING & ANALYTICS SOFTWARE, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 35 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 36 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 117 TABLE 37 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY REGION, 2023–2030 (USD MILLION) 118 TABLE 38 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 39 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR INFECTION CONTROL SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 40 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 120 TABLE 41 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 42 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLAIMS MANAGEMENT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION) 121 TABLE 43 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 44 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 124 TABLE 45 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR ON-PREMISE DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION) 125 TABLE 46 PATIENT SAFETY & RISK SOFTWARE MARKET FOR CLOUD-BASED DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 47 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HYBRID DEPLOYMENT, BY REGION, 2023–2030 (USD MILLION) 127 TABLE 48 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 129 TABLE 49 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 50 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 51 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 52 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICS, BY REGION, 2023–2030 (USD MILLION) 132 TABLE 53 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023–2030 (USD MILLION) 133 TABLE 54 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR LONG-TERM CARE CENTERS, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 55 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PHARMACIES, BY REGION, 2023–2030 (USD MILLION) 135 TABLE 56 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 57 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 58 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023–2030 (USD MILLION) 138 TABLE 59 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR MEDTECH COMPANIES, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 60 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 61 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION, 2023–2030 (USD MILLION) 141 TABLE 62 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 63 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 143 TABLE 64 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 65 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 66 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 67 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 68 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 146 TABLE 69 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 146 TABLE 70 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION) 147 TABLE 71 KEY ACTIVITIES IN US PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET 148 TABLE 72 US: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 148 TABLE 73 US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 148 TABLE 74 US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 75 US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 76 US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 149 TABLE 77 US: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 150 TABLE 78 US: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 150 TABLE 79 US: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 151 TABLE 80 CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET, BY FUNCTION, 2023–2030(USD MILLION) 152 TABLE 81 CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION) 152 TABLE 82 CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030(USD MILLION) 153 TABLE 83 CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030(USD MILLION) 153 TABLE 84 CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030(USD MILLION) 153 TABLE 85 CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 154 TABLE 86 CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030(USD MILLION) 154 TABLE 87 CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION) 155 TABLE 88 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030(USD MILLION) 156 TABLE 89 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030(USD MILLION) 156 TABLE 90 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION) 157 TABLE 91 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030(USD MILLION) 157 TABLE 92 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030(USD MILLION) 158 TABLE 93 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030(USD MILLION) 158 TABLE 94 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 158 TABLE 95 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030(USD MILLION) 159 TABLE 96 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030(USD MILLION) 159 TABLE 97 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030(USD MILLION) 160 TABLE 98 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030(USD MILLION) 161 TABLE 99 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 161 TABLE 100 GERMANY: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 101 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 102 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 162 TABLE 103 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 104 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 105 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 164 TABLE 106 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 107 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 108 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 109 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 166 TABLE 110 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 166 TABLE 111 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 167 TABLE 112 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 167 TABLE 113 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 168 TABLE 114 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 115 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 116 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 117 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 118 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 170 TABLE 119 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 171 TABLE 120 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 121 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 172 TABLE 122 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 123 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 173 TABLE 124 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 125 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 126 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 174 TABLE 127 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 128 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 129 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 176 TABLE 130 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 131 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 177 TABLE 132 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 133 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 134 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 178 TABLE 135 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 136 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 137 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 180 TABLE 138 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 139 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 181 TABLE 140 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 141 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 142 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 182 TABLE 143 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 183 TABLE 144 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 145 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 146 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 186 TABLE 147 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 148 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 149 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 187 TABLE 150 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 151 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 188 TABLE 152 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 189 TABLE 153 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 154 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 190 TABLE 155 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 156 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 157 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 158 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 159 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 192 TABLE 160 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 193 TABLE 161 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 162 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 194 TABLE 163 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 164 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 195 TABLE 165 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 166 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 167 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 196 TABLE 168 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 197 TABLE 169 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 170 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 198 TABLE 171 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 172 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 173 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 174 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 200 TABLE 175 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 200 TABLE 176 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 201 TABLE 177 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 178 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 202 TABLE 179 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 180 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 181 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 182 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 183 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 204 TABLE 184 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 205 TABLE 185 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 186 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 206 TABLE 187 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 188 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 189 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 190 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 191 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 208 TABLE 192 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 209 TABLE 193 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 209 TABLE 194 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 210 TABLE 195 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 196 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 197 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 198 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 199 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 212 TABLE 200 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 213 TABLE 201 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 202 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 214 TABLE 203 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 215 TABLE 204 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 215 TABLE 205 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 206 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 207 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 208 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 217 TABLE 209 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 218 TABLE 210 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 211 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 219 TABLE 212 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 213 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 214 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 215 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 216 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 221 TABLE 217 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 222 TABLE 218 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 219 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 223 TABLE 220 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 221 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 224 TABLE 222 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 223 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 224 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 225 TABLE 225 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 226 TABLE 226 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 227 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 227 TABLE 228 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 229 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 230 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 231 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 232 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 229 TABLE 233 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 230 TABLE 234 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 235 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 236 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 232 TABLE 237 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 238 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 239 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 240 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 241 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 234 TABLE 242 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 235 TABLE 243 MIDDLE EAST AND AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 244 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 236 TABLE 245 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 236 TABLE 246 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 247 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 248 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 249 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 250 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 238 TABLE 251 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 239 TABLE 252 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 253 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 240 TABLE 254 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 255 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 256 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 257 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 258 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 242 TABLE 259 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 243 TABLE 260 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 261 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 244 TABLE 262 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 263 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 264 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 265 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 266 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 246 TABLE 267 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 247 TABLE 268 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 269 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 248 TABLE 270 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 271 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 272 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 273 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 274 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 250 TABLE 275 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 251 TABLE 276 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 277 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 252 TABLE 278 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 279 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 280 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 281 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 282 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 254 TABLE 283 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 255 TABLE 284 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 285 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023–2030 (USD MILLION) 256 TABLE 286 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 287 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 288 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 289 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 290 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023–2030 (USD MILLION) 258 TABLE 291 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023–2030 (USD MILLION) 259 TABLE 292 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 293 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, JANUARY 2022–SEPTEMBER 2025 260 TABLE 294 PATIENT SAFETY AND RISK SOFTWARE MARKET: DEGREE OF COMPETITION 264 TABLE 295 PATIENT SAFETY AND RISK SOFTWARE MARKET: REGION FOOTPRINT 271 TABLE 296 PATIENT SAFETY AND RISK SOFTWARE MARKET: DEPLOYMENT MODE FOOTPRINT 272 TABLE 297 PATIENT SAFETY AND RISK SOFTWARE MARKET: FUNCTION FOOTPRINT 273 TABLE 298 PATIENT SAFETY AND RISK SOFTWARE MARKET: END-USER FOOTPRINT 274 TABLE 299 PATIENT SAFETY AND RISK SOFTWARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 277 TABLE 300 PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 277 TABLE 301 PATIENT SAFETY AND RISK SOFTWARE MARKET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 278 TABLE 302 PATIENT SAFETY AND RISK SOFTWARE MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025 279 TABLE 303 PATIENT SAFETY AND RISK SOFTWARE MARKET: EXPANSIONS, JANUARY 2022–AUGUST 2025 280 TABLE 304 RISKONNECT, INC.: COMPANY OVERVIEW 281 TABLE 305 RISKONNECT, INC.: SOLUTIONS OFFERED 282 TABLE 306 RISKONNECT, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 282 TABLE 307 RISKONNECT, INC.: DEALS, JANUARY 2022–SEPTEMBER 2025 283 TABLE 308 ORIGAMI RISK LLC: COMPANY OVERVIEW 284 TABLE 309 ORIGAMI RISK LLC: SOLUTIONS OFFERED 284 TABLE 310 ORIGAMI RISK LLC: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 285 TABLE 311 RLDATIX: COMPANY OVERVIEW 287 TABLE 312 RLDATIX: SOLUTIONS OFFERED 287 TABLE 313 RLDATIX: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 288 TABLE 314 RLDATIX: DEALS, JANUARY 2022–SEPTEMBER 2025 289 TABLE 315 RLDATIX: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 291 TABLE 316 HEALTH CATALYST: COMPANY OVERVIEW 292 TABLE 317 HEALTH CATALYST: SOLUTIONS OFFERED 293 TABLE 318 HEALTH CATALYST: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 294 TABLE 319 HEALTH CATALYST: DEALS, JANUARY 2022–SEPTEMBER 2025 294 TABLE 320 SYMPLR: COMPANY OVERVIEW 297 TABLE 321 SYMPLR: SOLUTIONS OFFERED 297 TABLE 322 SYMPLR: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 298 TABLE 323 SYMPLR: DEALS, JANUARY 2022–SEPTEMBER 2025 298 TABLE 324 CLARITY GROUP, INC.: COMPANY OVERVIEW 300 TABLE 325 CLARITY GROUP, INC.: SOLUTIONS OFFERED 300 TABLE 326 PERFORMANCE HEALTH PARTNERS: COMPANY OVERVIEW 301 TABLE 327 PERFORMANCE HEALTH PARTNERS: SOLUTIONS OFFERED 301 TABLE 328 PERFORMANCE HEALTH PARTNERS: DEALS, JANUARY 2022–SEPTEMBER 2025 302 TABLE 329 MORCARE: COMPANY OVERVIEW 303 TABLE 330 MORCARE: SOLUTIONS OFFERED 303 TABLE 331 RISKQUAL TECHNOLOGIES, INC.: COMPANY OVERVIEW 304 TABLE 332 RISKQUAL TECHNOLOGIES, INC.: SOLUTIONS OFFERED 304 TABLE 333 PRISTA CORPORATION: COMPANY OVERVIEW 305 TABLE 334 PRISTA CORPORATION: SOLUTIONS OFFERED 305 TABLE 335 SAFEQUAL: COMPANY OVERVIEW 306 TABLE 336 SAFEQUAL: SOLUTIONS OFFERED 306 TABLE 337 IQVIA: COMPANY OVERVIEW 307 TABLE 338 IQVIA: SOLUTIONS OFFERED 308 TABLE 339 IQVIA: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 309 TABLE 340 IQVIA: DEALS, JANUARY 2022–SEPTEMBER 2025 309 TABLE 341 INOVALON: COMPANY OVERVIEW 310 TABLE 342 INOVALON: SOLUTIONS OFFERED 310 TABLE 343 INOVALON: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 311 TABLE 344 NAVEX GLOBAL, INC.: COMPANY OVERVIEW 312 TABLE 345 NAVEX GLOBAL, INC.: SOLUTIONS OFFERED 312 TABLE 346 NAVEX GLOBAL, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 313 TABLE 347 NAVEX GLOBAL, INC.: DEALS, JANUARY 2022–SEPTEMBER 2024 314 TABLE 348 NAVEX GLOBAL, INC.: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025 314 TABLE 349 CENSINET: COMPANY OVERVIEW 315 TABLE 350 CENSINET: SOLUTIONS OFFERED 315 TABLE 351 CENSINET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 316 TABLE 352 AMERICAN DATA NETWORK: COMPANY OVERVIEW 317 TABLE 353 AMERICAN DATA NETWORK: SOLUTIONS OFFERED 317 TABLE 354 ARVENTA: COMPANY OVERVIEW 318 TABLE 355 ARVENTA: SOLUTIONS OFFERED 318 TABLE 356 COMPLIANCEQUEST: COMPANY OVERVIEW 319 TABLE 357 COMPLIANCEQUEST: SOLUTIONS OFFERED 319 TABLE 358 COMPLIANCEQUEST: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022–SEPTEMBER 2025 320 TABLE 359 COMPLIANCEQUEST: DEALS, JANUARY 2022–SEPTEMBER 2025 320 TABLE 360 RADAR HEALTHCARE INC: COMPANY OVERVIEW 321 TABLE 361 RADAR HEALTHCARE INC: SOLUTIONS OFFERED 321 TABLE 362 PASCAL METRICS INC.: COMPANY OVERVIEW 322 TABLE 363 PASCAL METRICS INC.: SOLUTIONS OFFERED 322 TABLE 364 OMNIGO: COMPANY OVERVIEW 323 TABLE 365 LOGICMANAGER, INC.: COMPANY OVERVIEW 324 TABLE 366 DEXUR: COMPANY OVERVIEW 325 TABLE 367 HEALTHCARE GRC PTE. LTD.: COMPANY OVERVIEW 326 TABLE 368 NOSOTECH INC.: COMPANY OVERVIEW 327 FIGURE 1 PATIENT SAFETY AND RISK SOFTWARE MARKET SEGMENTATION AND REGIONAL SCOPE 33 FIGURE 2 RESEARCH DESIGN 37 FIGURE 3 PRIMARY SOURCES 40 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 42 FIGURE 5 SUPPLY-SIDE MARKET ESTIMATION 43 FIGURE 6 PATIENT SAFETY AND RISK SOFTWARE MARKET: REVENUE ESTIMATION APPROACH 43 FIGURE 7 BOTTOM-UP APPROACH: END-USER SPENDING ON PATIENT SAFETY AND RISK SOFTWARE 45 FIGURE 8 CAGR PROJECTIONS FROM MARKET DYNAMICS, 2025–2030 47 FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 47 FIGURE 10 TOP-DOWN APPROACH 48 FIGURE 11 DATA TRIANGULATION METHODOLOGY 49 FIGURE 12 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2025 VS. 2030 (USD MILLION) 52 FIGURE 13 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2025 VS. 2030 (USD MILLION) 53 FIGURE 14 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 54 FIGURE 15 PATIENT SAFETY AND RISK SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT 55 FIGURE 16 GROWING HEALTHCARE EXPENDITURE AND RISING ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE MARKET 56 FIGURE 17 HEALTHCARE PROVIDERS AND US LED NORTH AMERICAN MARKET IN 2024 57 FIGURE 18 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 58 FIGURE 19 EMERGING MARKETS TO HAVE HIGHER GROWTH THAN DEVELOPED MARKETS DURING FORECAST PERIOD 59 FIGURE 20 PATIENT SAFETY AND RISK SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 60 FIGURE 21 REPORTS SUBMITTED TO PENNSYLVANIA'S PATIENT SAFETY REPORTING SYSTEM BY HOSPITALS, 2022–2024 62 FIGURE 22 REPORTS SUBMITTED TO PENNSYLVANIA'S PATIENT SAFETY REPORTING SYSTEM BY NON-HOSPITALS, 2022–2024 62 FIGURE 23 REVENUE SHIFT IN PATIENT SAFETY AND RISK SOFTWARE MARKET 70 FIGURE 24 PATIENT SAFETY AND RISK SOFTWARE MARKET: VALUE CHAIN ANALYSIS 72 FIGURE 25 PATIENT SAFETY AND RISK SOFTWARE MARKET: ECOSYSTEM ANALYSIS 74 FIGURE 26 PATIENT SAFETY AND RISK SOFTWARE MARKET: INVESTMENT AND FUNDING SCENARIO 76 FIGURE 27 PATIENT SAFETY AND RISK SOFTWARE MARKET: JURISDICTION AND TOP APPLICANT ANALYSIS, JANUARY 2022–SEPTEMBER 2025 79 FIGURE 28 PATIENT SAFETY AND RISK SOFTWARE MARKET: PATENT ANALYSIS, JANUARY 2015–SEPTEMBER 2025 80 FIGURE 29 PATIENT SAFETY AND RISK SOFTWARE MARKET: PORTER’S FIVE FORCES ANALYSIS 92 FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS 94 FIGURE 31 KEY BUYING CRITERIA FOR TOP THREE END USERS 95 FIGURE 32 MARKET POTENTIAL OF AI/GENERATIVE AI IN PATIENT SAFETY AND RISK SOFTWARE 99 FIGURE 33 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 101 FIGURE 34 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET SNAPSHOT 142 FIGURE 35 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET SNAPSHOT 185 FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, 2020–2024 (USD MILLION) 262 FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, 2024 263 FIGURE 38 PATIENT SAFETY AND RISK SOFTWARE MARKET: BRAND/SOFTWARE COMPARISON 266 FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 267 FIGURE 40 EV/EBITDA OF KEY VENDORS 267 FIGURE 41 PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 269 FIGURE 42 PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY FOOTPRINT 270 FIGURE 43 PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 276 FIGURE 44 HEALTH CATALYST: COMPANY SNAPSHOT (2024) 293 FIGURE 45 IQVIA: COMPANY SNAPSHOT (2024) 308